North America Vascular Stents Market Size, Share Analysis, Forecast 2024-32

North America Vascular Stents Market Overview 2024-2032

 The latest report by IMARC Group, titled “North America Vascular Stents Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032“, offers a comprehensive analysis of the industry, which comprises insights on the North America vascular stents market share. The North America vascular stents market size reached US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032.

 Vascular stents are small, expandable mesh-like tubes used to treat narrow or weakened arteries and veins. They are typically made from metal alloys such as stainless steel, cobalt-chromium, or nitinol, or from biocompatible polymers. The primary function of vascular stents is to provide structural support to the blood vessel, keeping it open and maintaining adequate blood flow to organs and tissues. During a medical procedure called angioplasty, a catheter with a deflated balloon and stent is inserted into the narrowed or blocked blood vessel. The balloon is inflated to widen the artery, and the stent expands against the artery wall, acting like a scaffold to keep the vessel open. Once in place, the balloon is deflated and removed, leaving the stent permanently in position to prevent the artery from narrowing again. At present, vascular stents are gaining immense traction across North America as they help reduce symptoms of conditions such as coronary artery disease, peripheral artery disease, and other vascular disorders, improving blood circulation and reducing the risk of complications.

North America Vascular Stents Market Trends and Drivers:

The North America vascular stents market is primarily driven by the aging population and the prevalence of cardiovascular diseases that have augmented the demand for vascular stents. As people live longer, there is a higher incidence of conditions like coronary artery disease and peripheral artery disease, necessitating interventions such as angioplasty with stent placement. Apart from this, ongoing technological advancements in stent design, including the development of drug-eluting stents and bioresorbable stents, enhance efficacy and patient outcomes, further fueling market expansion. These innovations reduce the risk of restenosis and thrombosis while promoting faster healing and recovery times. Moreover, the increasing adoption of minimally invasive procedures in cardiovascular treatments, which offer shorter hospital stays and quicker recovery periods compared to traditional surgeries, drives the demand for vascular stents. Moreover, favorable reimbursement policies and healthcare reforms supporting cardiovascular care contribute to market growth by improving patient access to stent procedures. Furthermore, ongoing research and development (R&D) activities aimed at improving stent materials and coatings, enhancing biocompatibility, and long-term performance is supporting market growth.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/north-america-vascular-stents-market/requestsample

North America Vascular Stents Market 2024-2032 Analysis and Segmentation:

The report segmented the market on the basis of product type, material, mode of delivery and end-user.

Market by Product Type

• Coronary Stents
• Peripheral Vascular Stents
• EVAR Stent Grafts

Market by Material

• Metallic Stents
• Cobalt Chromium
• Platinum Chromium
• Nickel Titanium
• Stainless Steel
• Others

Market by Mode of Delivery

• Balloon-Expandable Stents
• Self-Expanding Stents

Market by End-User

• Hospitals and Cardiac Centers
• Ambulatory Surgical Centers

Key highlights of the report:

• Market Performance (2018-2023)
• Market Outlook (2024- 2032)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145